Atlas Trials

A Randomized, Double-blind Clinical Investigation to Evaluate the Use of the Relievion™ Device in Treating Migraine.

Clinical trial NCT03185559 · TERMINATED

Trial details

NCT number
NCT03185559
Sponsor
Neurolief Ltd.
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Migraine
Start date
2017-07-23
Primary completion
2018-01-09
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.